ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma
Cancers · 28.01.2026 · 18 (3) · 424
DOI: 10.3390/cancers18030424 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 28.01.2026. Verfasst von Andreea Cătălina Tinca und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pathophysiology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cutaneous melanoma is one of the most aggressive skin cancers. Over the years, multiple studies have focused on identifying novel treatment strategies, with increasing attention directed toward immune-modulating mechanisms within the tumor microenvironment. Among these, ATP-binding cassette transporters and stem-associated pathways have been shown to influence drug response and immune escape. ABCB5 is a gene with multiple isoforms that significantly influences the immune response. In melanoma, the ABCB5α isoform is predominantly expressed, particularly in tumor stem-like cells where it promotes chemoresistance through active drug efflux. ABCB5 has also been linked to the regulation of PI3K/Akt, BCL-2, and miR-145-associated pathways. Moreover, ABCB5-positive cells contribute to the formation of an immunosuppressive microenvironment by secreting cytokines (IL-6, IL-8, TGF-β) and expressing immune checkpoint ligands, such as PD-L1, thereby favoring tumor progression and a poor prognosis. This review integrates current data on the molecular and microenvironmental mechanisms underlying melanoma progression and therapy resistance, and positions ABCB5 within the broader landscape of melanoma resistance mechanisms, emphasizing both its potential and its current limitations as a biomarker and therapeutic target.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pathophysiology Department, George Emil Palade University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania.
- Pathology Department, Clinical County Hospital Mureș, 540136 Târgu Mureș, Romania.
ORCID-Profile: Andreea Cătălina Tinca, Raluca-Diana Hagău, Iuliu Gabriel Cocuz, Raluca Niculescu, Irina Bianca Kosovski, Sofia Teodora Muntean, Sabin Gligore Turdean
Zitieren
APA
Tinca, A. C., Sabău, A. H., Cozac-Szoke, A. R., Chiorean, D. M., Lazar, B. A., Hagău, R. D., Cocuz, I. G., Niculescu, R., Kosovski, I. B., Muntean, S. T., Turdean, S. G., & Cotoi, O. S. (2026). ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma. Cancers, 18(3), 424. https://doi.org/10.3390/cancers18030424
Vancouver
Tinca AC, Sabău AH, Cozac-Szoke AR, Chiorean DM, Lazar BA, Hagău RD, et al. ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma. Cancers. 2026;18(3):424. doi:10.3390/cancers18030424
BibTeX
@article{Tinca2026,
author = {Tinca, Andreea Cătălina and Sabău, Adrian Horațiu and Cozac-Szoke, Andreea Raluca and Chiorean, Diana Maria and Lazar, Bianca Andreea and Hagău, Raluca-Diana and Cocuz, Iuliu Gabriel and Niculescu, Raluca and Kosovski, Irina Bianca and Muntean, Sofia Teodora and Turdean, Sabin Gligore and Cotoi, Ovidiu Simion},
title = {ABCB5: A Key Regulator Linking Stem Cell Plasticity, Tumor Microenvironment, and Therapy Resistance in Cutaneous Melanoma},
journal = {Cancers},
year = {2026},
volume = {18},
number = {3},
pages = {424},
doi = {10.3390/cancers18030424}
}
EUVIMED